Medical Sensor Employing Vibrating Cantilever, Key To DNA Detection
7/30/2012
A tiny vibrating cantilever sensor could soon help doctors and field clinicians quickly detect harmful toxins, bacteria and even indicators of certain types of cancer from small samples of blood or urine...
For decades, scientists have known that the effects of global climate change could have a potentially devastating impact across the globe, but Harvard researchers say there is now evidence that it may also have a dramatic impact on public health. As reported in a paper published in Science, a team of researchers led by James G. Anderson, the Philip S...
Patients with the most common type of lung cancer are notoriously insensitive to chemotherapy drugs, including cisplatin. New findings related to the cellular pathways that regulate responses to cisplatin have now been published by Cell Press in the journal Cell Reports...
Diagnostic Tests Followed By Personalized Medicine
7/30/2012
A new genre of medical tests - which determine whether a medicine is right for a patient's genes - are paving the way for increased use of personalized medicine, according to the cover story in the current edition of Chemical & Engineering News. C&EN; is the weekly newsmagazine of the American Chemical Society, the world's largest scientific society...
New Treatment Strategies For Brain Tumors Likely Following Genome Analysis
7/30/2012
Brain tumors are the primary cause of cancer mortality in children. Even if a cure is possible, young patients often suffer from the stressful treatment which can be harmful to the developing brain. The most common childhood brain tumors are medulloblastoma and pylocytic astrocytoma...
Outcomes Of Robotic Surgery: Data Presented At Head And Neck Cancer Annual Meeting
7/30/2012
Predictors of disease severity in human papillomavirus-derived head and neck cancer, tobacco use, and the dramatic benefits of robotic surgery in people with head and neck cancer are among landmark research presented by Mount Sinai School of Medicine at the Eighth International Conference on Head and Neck Cancer. The meeting took place from July 21-25, 2012 in Toronto...
Neoadjuvant Chemotherapy More Suitable For Breast Cancer Patients Who Lack RB Gene
7/30/2012
Breast cancer patients whose tumors lacked the retinoblastoma tumor suppressor gene (RB) had an improved pathological response to neoadjuvant chemotherapy, researchers at Thomas Jefferson University Hospital and the Kimmel Cancer Center at Jefferson report in a retrospective study published in a recent online issue of Clinical Cancer Research...
For Metastatic Melanoma, Should High-Dose Interleukin-2 Continue To Be The Treatment Of Choice?
7/29/2012
Administering high-doses of interleukin-2 (IL-2) has been the preferred treatment for patients with stage IV metastatic melanoma. An article published in the current issue of Cancer Biotherapy and Radiopharmaceuticals, a peer-reviewed journal from Mary Ann Liebert, Inc., explores whether or not this regimen is still the most effective...
Discovery Of A Genetic Cause Of Glioblastoma May Lead To New Treatment
7/29/2012
Researchers at Columbia University Medical Center (CUMC) have discovered that some cases of glioblastoma, the most common and aggressive form of primary brain cancer, are caused by the fusion of two adjacent genes. The study also found that drugs that target the protein produced by this genetic aberration can dramatically slow the growth of glioblastomas in mice...
Protein Discovery Links To Cancer Research
7/28/2012
A Simon Fraser University graduate student's collaboration with her thesis supervisor on how a particular type of protein controls the growth of another protein could advance cancer research. Their findings have just been published in the online issue of Current Biology, a CellPress journal...